|
Northern Ireland
|
Quadrisol 100 mg/ml Oral Gel for Horses
|
Grovet B.V.
|
EU/2/97/005/001,005
|
|
|
POM-V
|
|
|
Northern Ireland
|
VAXXON ND CLONE, Lyophilisate and Solvent for Oculonasal Suspension, for Chicken
|
IZO S.r.l a socio unico
|
EU/2/24/326/001-004
|
|
|
POM-V
|
|
|
Northern Ireland
|
Lotimax 900 mg Chewable Tablets for Dogs
|
Elanco GmbH
|
EU/2/24/311/005
|
|
|
POM-V
|
|
|
Northern Ireland
|
Lotimax 450 mg Chewable Tablets for Dogs
|
Elanco GmbH
|
EU/2/24/311/004
|
|
|
POM-V
|
|
|
Northern Ireland
|
Lotimax 225 mg Chewable Tablets for Dogs
|
Elanco GmbH
|
EU/2/24/311/003
|
|
|
POM-V
|
|
|
Northern Ireland
|
Lotimax 112 mg Chewable Tablets for Dogs
|
Elanco GmbH
|
EU/2/24/311/002
|
|
|
POM-V
|
|
|
Northern Ireland
|
Lotimax 56 mg Chewable Tablets for Dogs
|
Elanco GmbH
|
EU/2/24/311/001
|
|
|
POM-V
|
|
|
Northern Ireland
|
Mirataz 20 mg/ml Transdermal Ointment for Cats
|
Dechra Regulatory B.V.
|
EU/2/19/247/003
|
|
|
POM-V
|
|
|
Northern Ireland
|
Oncept IL-2 Lyophilisate and Solvent for Suspension for Injection for Cats
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/13/150/001
|
-
Feline interleukin-2 recombinant canarypox virus
|
|
POM-V
|
|
|
Northern Ireland
|
Melosus 0.5 mg/ml Oral Suspension for Cats and Guinea Pigs
|
CP Pharma Handelsgesellschaft mbH
|
EU/2/10/116/004,006-007
|
|
|
POM-V
|
|
|
Great Britain
|
BTVPUR Suspension for Injection for Sheep and Cattle
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5037
|
|
|
POM-V
|
|
|
Great Britain
|
Nexgard Spectra 150 mg / 30 mg Chewable Tablets for Dogs >30–60 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5036
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
|
Great Britain
|
Nexgard Spectra 75 mg / 15 mg Chewable Tablets for Dogs >15–30 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5035
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
|
Great Britain
|
Nexgard Spectra 38 mg / 8 mg Chewable Tablets for Dogs >7.5–15 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5034
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
|
Great Britain
|
Nexgard Spectra 19 mg / 4 mg Chewable Tablets for Dogs >3.5–7.5 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5033
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
|
Great Britain
|
Nexgard Spectra 9 mg / 2 mg Chewable Tablets for Dogs 1.35–3.5 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5032
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
|
Great Britain
|
NexGard 136 mg Chewable Tablets for Dogs >25-50 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5031
|
|
|
POM-V
|
|
|
Great Britain
|
NexGard 68 mg Chewable Tablets for Dogs >10-25 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5030
|
|
|
POM-V
|
|
|
Great Britain
|
NexGard 28 mg Chewable Tablets for Dogs >4-10 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5029
|
|
|
POM-V
|
|
|
Great Britain
|
NexGard 11 mg Chewable Tablets for Dogs 2-4 kg
|
Boehringer Ingelheim Vetmedica GmbH
|
61700/5028
|
|
|
POM-V
|
|